Prognosis

South Korea Resumes AstraZeneca Shots for Certain Age Groups

Photographer: SeongJoon Cho/Bloomberg
Lock
This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

South Korea will resume AstraZeneca Plc’s Covid-19 vaccine inoculations for those between the ages of 30 and 60 years as its health authorities balanced potential risks of the shots against a widening outbreak.